DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Diabetes Injection Pens Market, 2017 to 2025" report to their offering.
The global diabetes injection pens market was valued at US$ 5.6 Bn in 2016, and is expected to reach US$ 10.7 Bn by 2025, expanding at a CAGR of 7.2% from 2017 to 2025.
The global diabetes injection pens market is anticipated to progress at a considerable pace over the upcoming years due to increasing diabetes prevalence and corresponding rise in patients in need of regular insulin administration. Introduction of insulin pens and the subsequent smart insulin pens has significantly contributed to rapid proliferation of diabetes injection pens market. Furthermore, growing incidence of needlestick injury corresponding to growing users of insulin injections is additionally driving patients to opt for diabetes injection pens.
Among the considered regions, Europe is observed to be a saturated market with moderate movements, where introduction of breakthrough technology may bring an upswing in the market. United States is the largest revenue generating country-level market with large diabetes prevalence and better awareness and reimbursement for diabetes management. On the other hand, Asia Pacific is observed to be the fastest progressing regional market. Evolving healthcare infrastructure, improving awareness and growing healthcare expenditure majorly drive Asia Pacific diabetes injection pens market.
Becton, Dickinson and Company
Eli Lilly and Company
Jiangsu Delfu Co
Novo Nordisk A/S
Owen Mumford Ltd
Key Topics Covered:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Diabetes Injection Pens: Market Dynamics and Outlook
Chapter 4. Global Diabetes Injection Pens Market, by Indication, 2015 - 2025 (US$ Mn)
Chapter 5. Global Diabetes Injection Pens Market, by Product Type, 2015 - 2025 (US$ Mn)
Chapter 6. Global Diabetes Injection Pens Market, by Form, 2015 - 2025 (US$ Mn)
Chapter 7. Global Diabetes Injection Pens Market, by Geography, 2015 - 2025
Chapter 8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/n2s4x3/global_diabetes